Skip to main content
Top
Published in: Breast Cancer 6/2021

01-11-2021 | Case Report

New variant of breast-invasive lobular carcinoma with solid and encapsulated papillary carcinoma growth pattern

Authors: Xiaomei Li, Min Lin, Juan Xu, Yu Pang, Hongzhi Chen, Peng Sun, Gang Hou

Published in: Breast Cancer | Issue 6/2021

Login to get access

Abstract

To date, five cases of invasive lobular carcinoma with solid and encapsulated papillary carcinoma (SPC and EPC) growth pattern were reported. In this article, we describe such a case that might represent a diagnostic pitfall. A 61-year-old woman had a mass on the left breast that was characterized by multiple expansile nodules with a fibrous capsule. Tumor cells were arranged in a solid pattern with inconspicuous delicate fibrovascular cores, some were irregular glandular tubes and papillary, similar to the growth pattern of SPC and EPC. The appearance of the tumor surrounding tissue suggested a special type of lobular carcinoma. The diagnosis of invasive lobular carcinoma was confirmed by immunohistochemistry, which revealed negative E-cadherin, positive cytoplasmic P120, and deleted myoepithelium. Next-generation sequencing revealed CDH1 mutations that further proved the diagnosis of invasive lobular carcinoma. The main differential diagnoses for this tumor are SPC, EPC, neuroendocrine carcinoma, and secretory carcinoma, for which immunohistochemical analysis is an essential diagnostic tool. The growth pattern of invasive lobular carcinoma with EPC and SPC is a variant of the invasive lobular carcinoma newly discovered. The understanding of this variant expands the morphological spectrum of invasive lobular carcinoma and will help prevent misdiagnosis.
Literature
1.
go back to reference Li CI, Anderson BO, Daling JR, Moe RE. Trends in incidence rates of invasive lobular and ductal breast carcinoma. JAMA. 2003;289:1421–4.CrossRef Li CI, Anderson BO, Daling JR, Moe RE. Trends in incidence rates of invasive lobular and ductal breast carcinoma. JAMA. 2003;289:1421–4.CrossRef
2.
go back to reference Cserni G. Histological type and typing of breast carcinomas and the who classification changes over time. Pathologica. 2020;112:25–41.CrossRef Cserni G. Histological type and typing of breast carcinomas and the who classification changes over time. Pathologica. 2020;112:25–41.CrossRef
3.
go back to reference Rakha EA, Abbas A, Sheeran R. Invasive lobular carcinoma mimicking papillary carcinoma: a report of three cases. Pathobiol: J Immunopathol Mol Cell Biol. 2016;83:221–7.CrossRef Rakha EA, Abbas A, Sheeran R. Invasive lobular carcinoma mimicking papillary carcinoma: a report of three cases. Pathobiol: J Immunopathol Mol Cell Biol. 2016;83:221–7.CrossRef
4.
go back to reference Christgen M, Bartels S, van Luttikhuizen JL, Schieck M. Subclonal analysis in a lobular breast cancer with classical and solid growth pattern mimicking a solid-papillary carcinoma. J Pathol Clin Res. 2017;3:191–202.CrossRef Christgen M, Bartels S, van Luttikhuizen JL, Schieck M. Subclonal analysis in a lobular breast cancer with classical and solid growth pattern mimicking a solid-papillary carcinoma. J Pathol Clin Res. 2017;3:191–202.CrossRef
5.
go back to reference Motanagh SA, Muller KE. Invasive lobular carcinoma with papillary features: a newly described variant that poses a difficult histologic differential diagnosis. Breast J. 2020;26:1231–3. CrossRef Motanagh SA, Muller KE. Invasive lobular carcinoma with papillary features: a newly described variant that poses a difficult histologic differential diagnosis. Breast J. 2020;26:1231–3. CrossRef
6.
go back to reference Zhuang GF, Tan Y, Yang YZ, Zhang JW, Tang J. Experiment research of cisplatin implants inhibiting transplantation tumor growth and regulating the expression of klk7 and e-cad of tumor-bearing mice with gastric cancer. Asian Pac J Trop Med. 2016;9:606–9.CrossRef Zhuang GF, Tan Y, Yang YZ, Zhang JW, Tang J. Experiment research of cisplatin implants inhibiting transplantation tumor growth and regulating the expression of klk7 and e-cad of tumor-bearing mice with gastric cancer. Asian Pac J Trop Med. 2016;9:606–9.CrossRef
7.
go back to reference McCart Reed AE, Kutasovic JR, Lakhani SR, Simpson PT. Invasive lobular carcinoma of the breast: Morphology, biomarkers and ‘omics. Breast Cancer Res: BCR. 2015;17:12.CrossRef McCart Reed AE, Kutasovic JR, Lakhani SR, Simpson PT. Invasive lobular carcinoma of the breast: Morphology, biomarkers and ‘omics. Breast Cancer Res: BCR. 2015;17:12.CrossRef
8.
go back to reference Venhuizen JH, Span PN. P120 catenin isoforms differentially associate with breast cancer invasion and metastasis. Cancer (Basil). 2019;11:1459. CrossRef Venhuizen JH, Span PN. P120 catenin isoforms differentially associate with breast cancer invasion and metastasis. Cancer (Basil). 2019;11:1459. CrossRef
9.
go back to reference Dabbs DJ, Bhargava R, Chivukula M. Lobular versus ductal breast neoplasms: the diagnostic utility of p120 catenin. Am J Surg Pathol. 2007;31:427–37.CrossRef Dabbs DJ, Bhargava R, Chivukula M. Lobular versus ductal breast neoplasms: the diagnostic utility of p120 catenin. Am J Surg Pathol. 2007;31:427–37.CrossRef
10.
go back to reference Dabbs DJ, Schnitt SJ, Geyer FC, Weigelt B, Baehner FL, Decker T, et al. Lobular neoplasia of the breast revisited with emphasis on the role of e-cadherin immunohistochemistry. Am J Surg Pathol. 2013;37:e1-11.CrossRef Dabbs DJ, Schnitt SJ, Geyer FC, Weigelt B, Baehner FL, Decker T, et al. Lobular neoplasia of the breast revisited with emphasis on the role of e-cadherin immunohistochemistry. Am J Surg Pathol. 2013;37:e1-11.CrossRef
11.
go back to reference El Sharouni MA, Postma EL, van Diest PJ. Correlation between e-cadherin and p120 expression in invasive ductal breast cancer with a lobular component and mri findings. Virchows Arch: int j pathol. 2017;471:707–12.CrossRef El Sharouni MA, Postma EL, van Diest PJ. Correlation between e-cadherin and p120 expression in invasive ductal breast cancer with a lobular component and mri findings. Virchows Arch: int j pathol. 2017;471:707–12.CrossRef
12.
go back to reference Rakha EA, Gandhi N, Climent F, van Deurzen CH, Haider SA, Dunk L, et al. Encapsulated papillary carcinoma of the breast: an invasive tumor with excellent prognosis. Am J Surg Pathol. 2011;35:1093–103.CrossRef Rakha EA, Gandhi N, Climent F, van Deurzen CH, Haider SA, Dunk L, et al. Encapsulated papillary carcinoma of the breast: an invasive tumor with excellent prognosis. Am J Surg Pathol. 2011;35:1093–103.CrossRef
13.
go back to reference Tan BY, Thike AA, Ellis IO, Tan PH. Clinicopathologic characteristics of solid papillary carcinoma of the breast. Am J Surg Pathol. 2016;40:1334–42.CrossRef Tan BY, Thike AA, Ellis IO, Tan PH. Clinicopathologic characteristics of solid papillary carcinoma of the breast. Am J Surg Pathol. 2016;40:1334–42.CrossRef
14.
go back to reference Rosen LE, Gattuso P. Neuroendocrine tumors of the breast. Arch Pathol Lab Med. 2017;141:1577–81.CrossRef Rosen LE, Gattuso P. Neuroendocrine tumors of the breast. Arch Pathol Lab Med. 2017;141:1577–81.CrossRef
15.
go back to reference Li L, Wu N, Li F, Li L, Wei L, Liu J. Clinicopathologic and molecular characteristics of 44 patients with pure secretory breast carcinoma. Cancer Biol Med. 2019;16:139–46.CrossRef Li L, Wu N, Li F, Li L, Wei L, Liu J. Clinicopathologic and molecular characteristics of 44 patients with pure secretory breast carcinoma. Cancer Biol Med. 2019;16:139–46.CrossRef
Metadata
Title
New variant of breast-invasive lobular carcinoma with solid and encapsulated papillary carcinoma growth pattern
Authors
Xiaomei Li
Min Lin
Juan Xu
Yu Pang
Hongzhi Chen
Peng Sun
Gang Hou
Publication date
01-11-2021
Publisher
Springer Singapore
Published in
Breast Cancer / Issue 6/2021
Print ISSN: 1340-6868
Electronic ISSN: 1880-4233
DOI
https://doi.org/10.1007/s12282-021-01285-2

Other articles of this Issue 6/2021

Breast Cancer 6/2021 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine